Intended use:

The RIDASCREEN® UST Monitoring is an enzyme linked immunosorbent assay intended for the quantitative determination of ustekinumab (UST, Stelara®) in human serum and plasma.

Product information

Ustekinumab (UST, Stelara®) is a fully human monoclonal antibody that binds to the p40 subunit common to IL-12 and IL-23 thereby preventing the interaction with the cytokine receptors on T cells, natural killer cells and antigen-presenting cells.UST has been approved for treatment of moderate to severe Crohn’s disease (CD), plaque psoriasis and psoriatic arthritis.

The RIDASCREEN® UST Monitoring and our other TDM assays are vital to personalize treatment of patients to achieve better therapeutic targets.

Key features:

  • CE-marked version of the ELISA tests of KU Leuven
  • Highly specific antibodies
  • Ready to use reagents
  • Validated for use on automated ELISA systems, e.g. the Dynex DSX®
Specifications
Art. No. G09049
Test format Microtiter plate with 96 wells (12 strips with 8 removable wells each)
Incubation time 1 h 40 min
Files
InstructionsGerman
English
Spanish
French
Italian
SDSg09049_english.zip (English)
g09049_german.zip (German)
g09049_french.zip (French)
g09049_italian.zip (Italian)
g09049_spanish.zip (Spanish)
Similar products
RIDASCREEN® UST Monitoring
RIDASCREEN® UST Monitoring
The RIDASCREEN® UST Monitoring is an enzyme linked immunosorbent assay intended for the quantitative determination of ustekinumab (UST, Stelara®) i...
RIDASCREEN®GLM Monitoring
RIDASCREEN®GLM Monitoring
RIDASCREEN® GLM Monitoring is an enzyme linked immunoassay intended for the quantitative determination of golimumab (GLM, Simponi®) in human serum ...
RIDA®QUICK ADM Monitoring Control Set
RIDA®QUICK ADM Monitoring C...
For in vitro diagnostic use. The RIDA®QUICK ADM Monitoring Control Set is intended for the use with the corresponding, batch specific kit RIDA®QUIC...

Start typing and press Enter to search